未登录

J

Juan Antonio Navarro

instituto de investigación biomédica de málaga y plataforma en nanomedicina-ibima plataforma bionand

H指数:16

被引数:902

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Oral Administration of D-Chiro-Inositol Reverses Hippocampal Insulin and Glutamate Signaling Deficits in the 3×Tg Humanized Mouse Model of Alzheimer’s Disease

早期口服D-手性肌醇可逆转3×Tg人源化阿尔茨海默病小鼠模型中海马体的胰岛素和谷氨酸信号缺陷

Nutrients 2025, Vol. 17, Page 3024

IF5

2025-09-220

OAAI

Sex-specific alterations in emotional behavior and neurotransmitter systems in LPA1 receptor-deficient mice

LPA1受体缺陷小鼠中与性别相关的情绪行为和神经递质系统的改变

NEUROPHARMACOLOGY

IF4.6

2025-05-010

PRE

Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5xFAD Humanized Mouse Model of Alzheimer's Amyloidosis

IF5

2024-12-040

OAAI

Sex-based differences in growth-related IGF1 signaling in response to PAPP-A2 deficiency: comparative effects of rhGH, rhIGF1 and rhPAPP-A2 treatments

BIOLOGY OF SEX DIFFERENCES

IF5.1

2024-04-080

OAAI

Novel insights into D-Pinitol based therapies: a link between tau hyperphosphorylation and insulin resistance

NEURAL REGENERATION RESEARCH

IF6.7

2023-07-074

OAAI

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers

IF5

2022-10-016

OAAI

Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes

IF5.5

2022-07-302

OAAI

d-Pinitol promotes tau dephosphorylation through a cyclin-dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2022-07-1811

OAAI

Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer?s disease

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-06-014

OAAI

Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol

IF5

2021-06-3011

OAAI

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer's Disease in a Preclinical Model: A Therapeutic Opportunity

IF3.5

2020-11-0523

OAAI

D-Pinitol fromCeratonia siliquaIs an Orally Active Natural Inositol That Reduces Pancreas Insulin Secretion and Increases Circulating Ghrelin Levels in Wistar Rats

IF5

2020-07-0822

OAAI

Sex-Specific Anxiety and Prefrontal Cortex Glutamatergic Dysregulation Are Long-Term Consequences of Pre-and Postnatal Exposure to Hypercaloric Diet in a Rat Model

IF5

2020-06-1915

OAAI

The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats

SCIENTIFIC REPORTS

IF3.9

2018-06-2910

OAAI

REIMBURSEMENT OF CANCER DRUGS IN THE UK: NEW APPROACH TO END-OF-LLIFE TREATMENTS AND THE TECHNOLOGY APPRAISAL PROGRAMME OF NICE

VALUE IN HEALTH

IF6

2011-11-010

OAAI

SYNTHESIS, ELECTROCHEMISTRY, AND CRYSTAL-STRUCTURE OF N,N'-DICYANOQUINONEDIIMINE (DCNQI) DERIVATIVES CONTAINING FUSED BENZENE RINGS

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2002-05-0125

PREAI

In vitro pituitary and testicular effects of the leptin-related synthetic peptide leptin(116-130) amide involve actions both similar to and distinct from those of the native leptin molecule in the adult rat

EUROPEAN JOURNAL OF ENDOCRINOLOGY

IF5.2

2000-04-0147

OAAI

PROGRAM INDENTATION AND COMPREHENSIBILITY

COMMUNICATIONS OF THE ACM

IF12.2

1983-11-0185

OAAI